• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Richard Farquharson, Head of Supply Chain & Planning EMEA at AstraZeneca - Making the supply chain "sexy" - How to engage the commercial operations in pharmaceuticals supply management
 

Richard Farquharson, Head of Supply Chain & Planning EMEA at AstraZeneca - Making the supply chain "sexy" - How to engage the commercial operations in pharmaceuticals supply management

on

  • 1,090 views

Richard Farquharson, Head of Supply Chain & Planning EMEA at AstraZeneca spoke at the SCL Event 2013

Richard Farquharson, Head of Supply Chain & Planning EMEA at AstraZeneca spoke at the SCL Event 2013

Statistics

Views

Total Views
1,090
Views on SlideShare
1,089
Embed Views
1

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 1

http://www.linkedin.com 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Richard Farquharson, Head of Supply Chain & Planning EMEA at AstraZeneca - Making the supply chain "sexy" - How to engage the commercial operations in pharmaceuticals supply management Richard Farquharson, Head of Supply Chain & Planning EMEA at AstraZeneca - Making the supply chain "sexy" - How to engage the commercial operations in pharmaceuticals supply management Presentation Transcript

    • Making the pharma supply chain “SEXY” RICHARD FARQUHARSON AstraZeneca Pharmaceuticals Head of Supply Chain & Planning for EMEA
    • Lead times are long, inventory turnover low (Up to 400 days) ASEPTIC UK RoW Japan Italy EU Japan CH Italy Argentina Argentina 2
    • ? Reasonably predictable demand for ~10 years? ~ 12 years
    • Stock outs affect patient’s lives and aretherefore unacceptable
    • Regulatory Authority + Payer REGULATORPatient DR Pharmacist Patient PRESCRIBER DISPENSER CONSUMER DECISION MAKERS
    • So what has all this meant historically ? • Complete aversion to stock outs • Lots of inventory • Poor demand management & supply planning • Little agility, complex and highly regulated • Yet high gross margins • Limited perceived commercial “value” in what Operations has to offer
    • But things are rapidly changing... Increasing pressure on prices Even greater regulation Volatile emerging markets
    • SEXY SOTC Distribution Innovative channels Supply packagingReduction in cost Chain Top line sales security POS data Responsive supply chain Reduced S&OP working Range capital management Excellent Manage stock risk availability Dull
    • Supply chain security is a challenge
    • SEXY Accompanying Market diagnostics & access services ? Speed to Brand value proposition CoGs market SOTC Distribution Supply Innovative channels packagingReduction in cost Chain Top line sales security POS data Responsive supply chain Reduced S&OP working Range capital management Excellent Manage stock risk availability Dull
    • SEXY Accompanying Market diagnostics & access services ? Catalyse Speed to Lead CoGs SOTC & market Partner Distribution channels Supply Innovative packagingReduction in cost Chain Top line sales security POS data Responsive supply chain S&OP Range management Reduced working capital Just Do It Manage Excellent stock risk availability Dull
    • Why do we need to engage commercial ? Marketing provides customer insight Operations ensures product availability and manages risk....both are essential to deliver effective & efficient, future supply chains The 4Ps are not the sole property of marketing
    • How to engage Commercial? Partners not customers Get into the Commercial Business Take ownership of the whole supply chain: Right-to-Left thinking Bring innovative ideas and challenge the status quo
    • What are your experiences of engaging the commercial function